Add full model card
Browse files
README.md
CHANGED
|
@@ -1,199 +1,274 @@
|
|
| 1 |
---
|
| 2 |
-
|
| 3 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4 |
---
|
| 5 |
|
| 6 |
-
#
|
| 7 |
|
| 8 |
-
|
|
|
|
|
|
|
| 9 |
|
|
|
|
|
|
|
| 10 |
|
|
|
|
| 11 |
|
| 12 |
-
## Model
|
| 13 |
-
|
| 14 |
-
### Model Description
|
| 15 |
-
|
| 16 |
-
<!-- Provide a longer summary of what this model is. -->
|
| 17 |
-
|
| 18 |
-
This is the model card of a 🤗 transformers model that has been pushed on the Hub. This model card has been automatically generated.
|
| 19 |
-
|
| 20 |
-
- **Developed by:** [More Information Needed]
|
| 21 |
-
- **Funded by [optional]:** [More Information Needed]
|
| 22 |
-
- **Shared by [optional]:** [More Information Needed]
|
| 23 |
-
- **Model type:** [More Information Needed]
|
| 24 |
-
- **Language(s) (NLP):** [More Information Needed]
|
| 25 |
-
- **License:** [More Information Needed]
|
| 26 |
-
- **Finetuned from model [optional]:** [More Information Needed]
|
| 27 |
-
|
| 28 |
-
### Model Sources [optional]
|
| 29 |
-
|
| 30 |
-
<!-- Provide the basic links for the model. -->
|
| 31 |
-
|
| 32 |
-
- **Repository:** [More Information Needed]
|
| 33 |
-
- **Paper [optional]:** [More Information Needed]
|
| 34 |
-
- **Demo [optional]:** [More Information Needed]
|
| 35 |
-
|
| 36 |
-
## Uses
|
| 37 |
-
|
| 38 |
-
<!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
|
| 39 |
-
|
| 40 |
-
### Direct Use
|
| 41 |
-
|
| 42 |
-
<!-- This section is for the model use without fine-tuning or plugging into a larger ecosystem/app. -->
|
| 43 |
-
|
| 44 |
-
[More Information Needed]
|
| 45 |
-
|
| 46 |
-
### Downstream Use [optional]
|
| 47 |
-
|
| 48 |
-
<!-- This section is for the model use when fine-tuned for a task, or when plugged into a larger ecosystem/app -->
|
| 49 |
-
|
| 50 |
-
[More Information Needed]
|
| 51 |
-
|
| 52 |
-
### Out-of-Scope Use
|
| 53 |
-
|
| 54 |
-
<!-- This section addresses misuse, malicious use, and uses that the model will not work well for. -->
|
| 55 |
-
|
| 56 |
-
[More Information Needed]
|
| 57 |
-
|
| 58 |
-
## Bias, Risks, and Limitations
|
| 59 |
-
|
| 60 |
-
<!-- This section is meant to convey both technical and sociotechnical limitations. -->
|
| 61 |
-
|
| 62 |
-
[More Information Needed]
|
| 63 |
-
|
| 64 |
-
### Recommendations
|
| 65 |
-
|
| 66 |
-
<!-- This section is meant to convey recommendations with respect to the bias, risk, and technical limitations. -->
|
| 67 |
-
|
| 68 |
-
Users (both direct and downstream) should be made aware of the risks, biases and limitations of the model. More information needed for further recommendations.
|
| 69 |
-
|
| 70 |
-
## How to Get Started with the Model
|
| 71 |
-
|
| 72 |
-
Use the code below to get started with the model.
|
| 73 |
-
|
| 74 |
-
[More Information Needed]
|
| 75 |
-
|
| 76 |
-
## Training Details
|
| 77 |
-
|
| 78 |
-
### Training Data
|
| 79 |
-
|
| 80 |
-
<!-- This should link to a Dataset Card, perhaps with a short stub of information on what the training data is all about as well as documentation related to data pre-processing or additional filtering. -->
|
| 81 |
-
|
| 82 |
-
[More Information Needed]
|
| 83 |
-
|
| 84 |
-
### Training Procedure
|
| 85 |
-
|
| 86 |
-
<!-- This relates heavily to the Technical Specifications. Content here should link to that section when it is relevant to the training procedure. -->
|
| 87 |
-
|
| 88 |
-
#### Preprocessing [optional]
|
| 89 |
-
|
| 90 |
-
[More Information Needed]
|
| 91 |
-
|
| 92 |
-
|
| 93 |
-
#### Training Hyperparameters
|
| 94 |
-
|
| 95 |
-
- **Training regime:** [More Information Needed] <!--fp32, fp16 mixed precision, bf16 mixed precision, bf16 non-mixed precision, fp16 non-mixed precision, fp8 mixed precision -->
|
| 96 |
-
|
| 97 |
-
#### Speeds, Sizes, Times [optional]
|
| 98 |
|
| 99 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
| 100 |
|
| 101 |
-
|
| 102 |
|
| 103 |
-
##
|
| 104 |
|
| 105 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 106 |
|
| 107 |
-
|
| 108 |
|
| 109 |
-
##
|
| 110 |
|
| 111 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 112 |
|
| 113 |
-
|
| 114 |
|
| 115 |
-
##
|
| 116 |
|
| 117 |
-
|
|
|
|
|
|
|
| 118 |
|
| 119 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 120 |
|
| 121 |
-
|
| 122 |
|
| 123 |
-
|
| 124 |
|
| 125 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
| 126 |
|
| 127 |
-
|
| 128 |
|
| 129 |
-
|
|
|
|
|
|
|
|
|
|
| 130 |
|
| 131 |
-
|
| 132 |
|
|
|
|
| 133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 134 |
|
| 135 |
-
|
|
|
|
| 136 |
|
| 137 |
-
|
|
|
|
| 138 |
|
| 139 |
-
|
|
|
|
|
|
|
| 140 |
|
| 141 |
-
|
|
|
|
|
|
|
|
|
|
| 142 |
|
| 143 |
-
|
|
|
|
|
|
|
|
|
|
| 144 |
|
| 145 |
-
|
|
|
|
| 146 |
|
| 147 |
-
|
| 148 |
-
|
| 149 |
-
|
| 150 |
-
|
| 151 |
-
|
| 152 |
|
| 153 |
-
##
|
|
|
|
|
|
|
| 154 |
|
| 155 |
-
|
| 156 |
|
| 157 |
-
|
| 158 |
|
| 159 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 160 |
|
| 161 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
| 162 |
|
| 163 |
-
|
|
|
|
|
|
|
| 164 |
|
| 165 |
-
|
| 166 |
|
| 167 |
-
##
|
| 168 |
|
| 169 |
-
|
|
|
|
|
|
|
|
|
|
| 170 |
|
| 171 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
| 172 |
|
| 173 |
-
|
|
|
|
|
|
|
|
|
|
| 174 |
|
| 175 |
-
**
|
|
|
|
| 176 |
|
| 177 |
-
|
| 178 |
|
| 179 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 180 |
|
| 181 |
-
|
| 182 |
|
| 183 |
-
##
|
| 184 |
|
| 185 |
-
|
| 186 |
|
| 187 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 188 |
|
| 189 |
-
|
| 190 |
|
| 191 |
-
|
| 192 |
|
| 193 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 194 |
|
| 195 |
-
|
| 196 |
|
| 197 |
-
##
|
| 198 |
|
| 199 |
-
|
|
|
|
|
|
| 1 |
---
|
| 2 |
+
language:
|
| 3 |
+
- en
|
| 4 |
+
license: apache-2.0
|
| 5 |
+
tags:
|
| 6 |
+
- biology
|
| 7 |
+
- protein
|
| 8 |
+
- longevity
|
| 9 |
+
- aging
|
| 10 |
+
- ESM-2
|
| 11 |
+
- LoRA
|
| 12 |
+
- sequence-classification
|
| 13 |
+
datasets:
|
| 14 |
+
- GenAge
|
| 15 |
+
- SwissProt
|
| 16 |
+
metrics:
|
| 17 |
+
- auprc
|
| 18 |
+
- roc_auc
|
| 19 |
+
base_model: facebook/esm2_t30_150M_UR50D
|
| 20 |
---
|
| 21 |
|
| 22 |
+
# Longevity Protein Classifier v6
|
| 23 |
|
| 24 |
+
Fine-tuned ESM-2 150M for binary classification of protein sequences
|
| 25 |
+
as longevity-associated or not, trained on multi-species GenAge data
|
| 26 |
+
with LoRA adapters.
|
| 27 |
|
| 28 |
+
Built as part of a personal ML learning arc — Week 3 of 8 —
|
| 29 |
+
connecting protein language models to longevity biology.
|
| 30 |
|
| 31 |
+
---
|
| 32 |
|
| 33 |
+
## Model Description
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 34 |
|
| 35 |
+
- **Model type:** ESM-2 150M + LoRA (r=16) sequence classifier
|
| 36 |
+
- **Base model:** facebook/esm2_t30_150M_UR50D
|
| 37 |
+
- **Task:** Binary classification — longevity-associated vs non-longevity
|
| 38 |
+
- **Developed by:** Mo Elzek
|
| 39 |
+
- **License:** Apache 2.0
|
| 40 |
|
| 41 |
+
---
|
| 42 |
|
| 43 |
+
## Performance
|
| 44 |
|
| 45 |
+
| Metric | Value |
|
| 46 |
+
|--------|-------|
|
| 47 |
+
| Test AUPRC | 0.335 |
|
| 48 |
+
| Test AUC-ROC | 0.696 |
|
| 49 |
+
| Random AUPRC baseline | 0.061 |
|
| 50 |
+
| Improvement over random | 5.5x |
|
| 51 |
+
| Training epochs | 10 (early stopping) |
|
| 52 |
|
| 53 |
+
---
|
| 54 |
|
| 55 |
+
## Benchmark Results
|
| 56 |
|
| 57 |
+
| Protein | Score | Expected | Notes |
|
| 58 |
+
|---------|-------|----------|-------|
|
| 59 |
+
| SIRT1 | 0.996 | HIGH | NAD+ deacetylase, caloric restriction mediator |
|
| 60 |
+
| SIRT3 | 0.998 | HIGH | Mitochondrial sirtuin |
|
| 61 |
+
| TP53 | 0.974 | HIGH | Tumour suppressor, aging roles |
|
| 62 |
+
| MYH9 | 0.000 | LOW | Structural myosin — negative control |
|
| 63 |
+
| ACTB | 0.000 | LOW | Beta actin — negative control |
|
| 64 |
+
| ALB | 0.000 | LOW | Serum albumin — negative control |
|
| 65 |
+
| FOXO3 | 0.000 | HIGH | **Fails** — see limitations |
|
| 66 |
+
| MTOR | 0.000 | HIGH | **Fails** — see limitations |
|
| 67 |
+
| TERT | 0.000 | HIGH | **Fails** — see limitations |
|
| 68 |
|
| 69 |
+
---
|
| 70 |
|
| 71 |
+
## Novel Predictions Not in GenAge
|
| 72 |
|
| 73 |
+
Proteins scoring above 0.50 that are not present in GenAge human
|
| 74 |
+
database. These are the model's predictions of longevity-relevant
|
| 75 |
+
proteins not yet catalogued — not validated findings.
|
| 76 |
|
| 77 |
+
| Protein | Score | Biological relevance |
|
| 78 |
+
|---------|-------|----------------------|
|
| 79 |
+
| TFEB | 0.502 | Master regulator of autophagy and lysosomal biogenesis. Overexpression extends lifespan in C. elegans. Regulated by mTOR. Strongest novel prediction. |
|
| 80 |
+
| NEIL1 | 0.951 | DNA glycosylase, base excision repair of oxidative damage. DNA repair capacity correlates with species lifespan. |
|
| 81 |
+
| GSTA1 | 0.871 | Glutathione S-transferase. Antioxidant defence. GST family implicated in longevity across multiple species. |
|
| 82 |
+
| GRHL1 | 0.880 | Grainyhead-like transcription factor. Epithelial barrier maintenance — tissue integrity declines with age. |
|
| 83 |
+
| EXO1 | 0.550 | Exonuclease involved in DNA mismatch repair and double-strand break repair. |
|
| 84 |
+
| MSH4 | 0.546 | DNA mismatch repair. Related family members (MSH2, MSH6) are established longevity-associated genes. |
|
| 85 |
|
| 86 |
+
---
|
| 87 |
|
| 88 |
+
## Recommended Thresholds
|
| 89 |
|
| 90 |
+
| Use case | Threshold | Precision | Recall |
|
| 91 |
+
|----------|-----------|-----------|--------|
|
| 92 |
+
| Screening — cast wide net | 0.05 | ~0.20 | ~29% |
|
| 93 |
+
| Balanced | 0.06 | ~0.41 | ~29% |
|
| 94 |
+
| High confidence hits only | 0.50 | ~0.61 | ~24% |
|
| 95 |
|
| 96 |
+
Optimised threshold from val set: **0.06** (F1: 0.358)
|
| 97 |
|
| 98 |
+
The model produces a bimodal distribution — proteins it recognises
|
| 99 |
+
score very high (above 0.50), proteins it does not score near zero.
|
| 100 |
+
The flat recall curve from 0.05 to 0.70 reflects this — most
|
| 101 |
+
longevity proteins are either clearly found or clearly missed.
|
| 102 |
|
| 103 |
+
---
|
| 104 |
|
| 105 |
+
## Known Limitations — Read Before Use
|
| 106 |
|
| 107 |
+
### 1. Protein length truncation
|
| 108 |
+
Sequences longer than 512 amino acids are truncated from the
|
| 109 |
+
C-terminus. This causes systematic failures on long proteins where
|
| 110 |
+
the functional domain sits in the C-terminal half:
|
| 111 |
|
| 112 |
+
- **MTOR** (2,549 aa): kinase domain at residues 2181-2431 — truncated away
|
| 113 |
+
- **TERT** (1,132 aa): reverse transcriptase domain at 600-900 — truncated away
|
| 114 |
|
| 115 |
+
Do not use this model to score proteins above 800 amino acids
|
| 116 |
+
without validating on known examples from that protein family first.
|
| 117 |
|
| 118 |
+
### 2. Family-specific blind spots
|
| 119 |
+
The model learned sirtuin and tumour suppressor sequence features
|
| 120 |
+
well but has insufficient training examples to generalise to:
|
| 121 |
|
| 122 |
+
- **Forkhead transcription factors** (FOXO3 scores 0.000 despite
|
| 123 |
+
being a canonical longevity gene and fitting within the 512 aa window)
|
| 124 |
+
- **Large kinases** (truncation compounds this)
|
| 125 |
+
- **Telomerase complex** proteins
|
| 126 |
|
| 127 |
+
### 3. Direction of effect not captured
|
| 128 |
+
The model cannot distinguish between:
|
| 129 |
+
- Pro-longevity proteins (overexpression extends lifespan)
|
| 130 |
+
- Anti-aging-disease proteins (loss of function accelerates aging)
|
| 131 |
|
| 132 |
+
Both may score high. A high score means "associated with longevity
|
| 133 |
+
biology" not "activating this protein extends lifespan."
|
| 134 |
|
| 135 |
+
### 4. Not validated experimentally
|
| 136 |
+
Novel predictions are model outputs only. No wet lab validation has
|
| 137 |
+
been performed. TFEB is the strongest prediction based on prior
|
| 138 |
+
literature but this model did not discover TFEB — it independently
|
| 139 |
+
ranked it highly, consistent with existing biology.
|
| 140 |
|
| 141 |
+
### 5. Not for clinical use
|
| 142 |
+
This is a research screening tool. Do not use for any clinical,
|
| 143 |
+
diagnostic, or therapeutic decision-making.
|
| 144 |
|
| 145 |
+
---
|
| 146 |
|
| 147 |
+
## Training Data
|
| 148 |
|
| 149 |
+
**Positive set:** GenAge database (genomics.senescence.info)
|
| 150 |
+
- Human GenAge: 306 human longevity-associated genes
|
| 151 |
+
- Model organism GenAge: Pro-Longevity genes only from 4 species
|
| 152 |
+
- C. elegans: 283 genes
|
| 153 |
+
- D. melanogaster: 125 genes
|
| 154 |
+
- M. musculus: 85 genes
|
| 155 |
+
- Total positives: ~574
|
| 156 |
|
| 157 |
+
**Negative set:** Swiss-Prot reviewed proteins from same species
|
| 158 |
+
- Sampled proportionally per species (NEG_RATIO=10)
|
| 159 |
+
- Species weights applied: human 2.0x, mouse 1.5x, worm/fly 1.0x
|
| 160 |
+
- "Necessary for fitness" genes excluded from universe entirely
|
| 161 |
+
- Anti-Longevity genes excluded from positives
|
| 162 |
|
| 163 |
+
**Filtering:**
|
| 164 |
+
- Sequence length: 50-1500 amino acids
|
| 165 |
+
- Swiss-Prot reviewed only (manually curated)
|
| 166 |
|
| 167 |
+
---
|
| 168 |
|
| 169 |
+
## Training Procedure
|
| 170 |
|
| 171 |
+
**Architecture:** ESM-2 150M + LoRA adapters
|
| 172 |
+
- LoRA rank: r=16, alpha=32, dropout=0.15
|
| 173 |
+
- Target modules: query, value attention projections
|
| 174 |
+
- Trainable parameters: ~4.7M of 150M total (3.1%)
|
| 175 |
|
| 176 |
+
**Loss function:** Focal loss with contrastive margin penalty
|
| 177 |
+
- gamma=1.0 (softer than standard gamma=2.0)
|
| 178 |
+
- Label smoothing=0.1
|
| 179 |
+
- Contrastive margin=0.30 (explicit separation penalty)
|
| 180 |
+
- Class weights: balanced
|
| 181 |
|
| 182 |
+
**Optimiser:** AdamW, lr=2e-4, weight_decay=0.01
|
| 183 |
+
**Schedule:** Cosine with warmup (10% warmup steps)
|
| 184 |
+
**Early stopping:** Patience=4 on val AUPRC
|
| 185 |
+
**Best epoch:** 10 of 20
|
| 186 |
|
| 187 |
+
**Hardware:** NVIDIA T4 16GB (Kaggle)
|
| 188 |
+
**Training time:** ~2 hours
|
| 189 |
|
| 190 |
+
---
|
| 191 |
|
| 192 |
+
## How to Use
|
| 193 |
+
```
|
| 194 |
+
from transformers import AutoTokenizer, EsmForSequenceClassification
|
| 195 |
+
from peft import PeftModel
|
| 196 |
+
import torch
|
| 197 |
+
|
| 198 |
+
# Load model
|
| 199 |
+
base = EsmForSequenceClassification.from_pretrained(
|
| 200 |
+
"facebook/esm2_t30_150M_UR50D",
|
| 201 |
+
num_labels=2,
|
| 202 |
+
ignore_mismatched_sizes=True
|
| 203 |
+
)
|
| 204 |
+
model = PeftModel.from_pretrained(base, "YOUR_USERNAME/longevity-esm2-v6")
|
| 205 |
+
tokenizer = AutoTokenizer.from_pretrained("YOUR_USERNAME/longevity-esm2-v6")
|
| 206 |
+
|
| 207 |
+
device = torch.device("cuda" if torch.cuda.is_available() else "cpu")
|
| 208 |
+
model = model.to(device)
|
| 209 |
+
model.eval()
|
| 210 |
+
|
| 211 |
+
def score_sequence(sequence, threshold=0.06):
|
| 212 |
+
inputs = tokenizer(
|
| 213 |
+
sequence,
|
| 214 |
+
max_length=512,
|
| 215 |
+
padding="max_length",
|
| 216 |
+
truncation=True,
|
| 217 |
+
return_tensors="pt"
|
| 218 |
+
)
|
| 219 |
+
with torch.no_grad():
|
| 220 |
+
outputs = model(
|
| 221 |
+
input_ids=inputs["input_ids"].to(device),
|
| 222 |
+
attention_mask=inputs["attention_mask"].to(device)
|
| 223 |
+
)
|
| 224 |
+
prob = torch.softmax(outputs.logits, dim=1)[:, 1].item()
|
| 225 |
+
return {
|
| 226 |
+
"probability": round(prob, 4),
|
| 227 |
+
"prediction": "Longevity" if prob >= threshold else "Non-longevity",
|
| 228 |
+
"threshold": threshold,
|
| 229 |
+
"warning": "Truncated to 512 aa" if len(sequence) > 512 else None
|
| 230 |
+
}
|
| 231 |
+
|
| 232 |
+
# Example
|
| 233 |
+
result = score_sequence("MKTAYIAKQRQISFVK...")
|
| 234 |
+
print(result)
|
| 235 |
+
```
|
| 236 |
+
|
| 237 |
+
**Recommended thresholds:**
|
| 238 |
+
- 0.05-0.06 for screening (maximise recall)
|
| 239 |
+
- 0.50 for high-confidence hits only
|
| 240 |
|
| 241 |
+
---
|
| 242 |
|
| 243 |
+
## Experiment History
|
| 244 |
|
| 245 |
+
This model is v6 in a series of iterative experiments:
|
| 246 |
|
| 247 |
+
| Version | Key change | Test AUPRC |
|
| 248 |
+
|---------|-----------|------------|
|
| 249 |
+
| v1 | Frozen encoder, 186 positives | Collapsed |
|
| 250 |
+
| v2 | LoRA r=8, 277 positives | 0.027 |
|
| 251 |
+
| v3 | ESM-2 150M, multi-species, ~2000 positives | 0.302 |
|
| 252 |
+
| v4 | Pro-Longevity filter, focal loss gamma=2 | 0.250 |
|
| 253 |
+
| v5 | Cleaned species, gamma=1, label smoothing | 0.323 |
|
| 254 |
+
| v6 (this) | Pathway-stratified split, contrastive margin | **0.335** |
|
| 255 |
|
| 256 |
+
---
|
| 257 |
|
| 258 |
+
## Citation
|
| 259 |
|
| 260 |
+
If you use this model in research, please cite:
|
| 261 |
+
@misc{elzek2026longevity,
|
| 262 |
+
author = {Elzek, Mo},
|
| 263 |
+
title = {Longevity Protein Classifier: Multi-species ESM-2 Fine-tuning},
|
| 264 |
+
year = {2026},
|
| 265 |
+
publisher = {HuggingFace},
|
| 266 |
+
url = {https://huggingface.co/YOUR_USERNAME/longevity-esm2-v6}
|
| 267 |
+
}
|
| 268 |
|
| 269 |
+
---
|
| 270 |
|
| 271 |
+
## Contact
|
| 272 |
|
| 273 |
+
Built by Mo Elzek as part of the London Longevity Network ML project arc.
|
| 274 |
+
Feedback and collaboration welcome.
|